Amy L. McGuire, Holly Fernandez Lynch, Lewis A. Grossman,, I. Glenn Cohen; Science This article discusses the regulatory challenges faced in the development of psychedelic medicine. It highlights the growing interest, investment in psychedelic drug development, the complexities of applying traditional clinical trial, premarket approval processes to these substances. The article emphasizes the need for…